Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 26, 2018 (Event Date); Signed February 16, 2018
Business Context: The Company entered into a financing agreement to facilitate the market placement of its dermaPACE System.
Key Financial Metrics
This filing reports on a specific material agreement rather than periodic financial performance. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, or existing debt levels.
- New Financing Facility: Master Equipment Lease line of credit up to $1,000,000.
- Lease Term: 36 months.
- Collateral: Security interest granted to NFS Leasing Inc. in the Company's accounts receivable, personal property, and money/deposit accounts.
Material Changes
The primary material change is the creation of a direct financial obligation through the Master Equipment Lease with NFS Leasing Inc. dated January 26, 2018. This agreement establishes a new debt facility intended to fund equipment purchases for the dermaPACE System.
Guidance, Outlook, and Risks
Outlook: The financing is intended to enable the Company to begin placing the dermaPACE System in the marketplace. The filing includes a press release (Exhibit 99.1) issued on February 12, 2018, regarding this agreement.
Risks and Forward-Looking Statements: The filing contains a cautionary statement regarding forward-looking information. Risks include uncertainties that may cause actual results to differ from projections regarding future revenue, earnings, and cash availability. Investors are directed to the "Risk Factors" section of the Company's Annual Report on Form 10-K for a comprehensive list of risks.
Investor Verification Checklist
- Verify the specific terms and interest rates within the Master Equipment Lease (Exhibit 10.1).
- Review the Company's current liquidity position to assess the impact of the security interest on accounts receivable and deposit accounts.
- Examine the February 12, 2018 press release (Exhibit 99.1) for additional details on the deployment strategy for the dermaPACE System.
- Consult the most recent Form 10-K for historical financial data and detailed risk factors not included in this 8-K.